CORDIS: Leveraging AI for more reliable predictions of immunotherapy in lung cancer

November, 3 2026 - < 1 min read

๐Ÿ”ฌ Can AI actually help doctors make better immunotherapy outcome predictions for lung cancer patients?

This is one of the key challenges the I3LUNG project is addressing.

By combining clinical, molecular and imaging data with advanced AI technologies, I3LUNG aims to improve the prediction of immunotherapy responses and support more personalized treatment decisions for patients with lung cancer.

We are proud to see our work in this recent article, featured by CORDIS, the European Commission‘s platform for showcasing the results of EU-funded research and innovation projects:

๐Ÿ“– ๐‹๐ž๐ฏ๐ž๐ซ๐š๐ ๐ข๐ง๐  ๐€๐ˆ ๐Ÿ๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐ซ๐ž๐ฅ๐ข๐š๐›๐ฅ๐ž ๐ฉ๐ซ๐ž๐๐ข๐œ๐ญ๐ข๐จ๐ง๐ฌ ๐จ๐Ÿ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐ข๐ง ๐ฅ๐ฎ๐ง๐  ๐œ๐š๐ง๐œ๐ž๐ซ: link here

A big thank you to all partners contributing to this ambitious effort to bring AI closer to clinical practice and improve outcomes for patients.

I3LUNG LungCancer AI ArtificialIntelligence Immunotherapy PrecisionMedicine CancerResearch HorizonEurope EuresearchResults CordisEU

Stay tuned for more information and donโ€™t forget to follow us on our social networks:

LinkedIn | Twitter | Instagram | Facebook

Share on: